Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Eagle Pharmaceuticals Inc. (EGRX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Hudson Executive Capital

Douglas Braunstein And James Woolery 

971,000 $39,122 3.99%
2. 1,050,000 $42,304 +42% 2.09%
3.
Fondren Management

Bradley Louis Radoff

15,000 $604 0.78%
4. 291,600 $11,749 0.55%
5.
Algert Coldiron Investors

Peter Algert And Kevin Coldiron

21,779 $877 +255% 0.24%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$55.45 350 Officer 700 2017-08-16 Filing
$50.09 1,584 Director 971,000 2017-08-09 Filing
$49.21 15,206 Director 969,416 2017-08-09 Filing
$48.06 3,610 Director 954,210 2017-08-09 Filing
$71.49 350 Officer 350 2017-06-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$51.81 12,428 Large Shareholder, Officer, Director 1,525,177 2019-03-01 Filing
$50.51 12,000 Large Shareholder, Officer, Director 1,537,605 2019-03-01 Filing
$42.30 900 Large Shareholder, Officer, Director 1,549,605 2019-02-01 Filing
$41.52 29,185 Large Shareholder, Officer, Director 1,550,505 2019-02-01 Filing
$40.57 302 Large Shareholder, Officer, Director 1,518,390 2019-01-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 33,939 $1,331 0.56%
2. 135,554 $5,461,471 0.44%
3. 24,000 $967 0.26%
4. 25,000 $1,007 0.24%
5. 32,400 $1,305 0.15%
News See All